Home » Archive by Category

News

Original content and news from BioSpace, Xconomy, Marketwire and other sources, specific to the region.

Agreement With City Would Keep Key Illumina Operations in San Diego

July 15, 2014 – 5:00 pm | Edit Post

The city of San Diego plans to provide Illumina Inc. with tax rebates that should ensure the company keeps 300 middle-class manufacturing jobs in town, Mayor Kevin Faulconer announced.

One injection stops diabetes in its tracks

July 15, 2014 – 5:00 pm | Edit Post

LA JOLLA—In mice with diet-induced diabetes—the equivalent of type 2 diabetes in humans—a single injection of the protein FGF1 is enough to restore blood sugar levels to a healthy range for more than two days. The discovery by Salk scientists, published today in the journal Nature, could lead to a new generation of safer, more effective diabetes drugs.

One injection stops diabetes in its tracks

July 15, 2014 – 5:00 pm | Edit Post

LA JOLLA—In mice with diet-induced diabetes—the equivalent of type 2 diabetes in humans—a single injection of the protein FGF1 is enough to restore blood sugar levels to a healthy range for more than two days. The discovery by Salk scientists, published today in the journal Nature, could lead to a new generation of safer, more effective diabetes drugs.

One injection stops diabetes in its tracks

July 15, 2014 – 5:00 pm | Edit Post

LA JOLLA—In mice with diet-induced diabetes—the equivalent of type 2 diabetes in humans—a single injection of the protein FGF1 is enough to restore blood sugar levels to a healthy range for more than two days. The discovery by Salk scientists, published today in the journal Nature, could lead to a new generation of safer, more effective diabetes drugs.

Genes promote hardening of arteries in type 2 diabetes

July 15, 2014 – 1:46 pm | Edit Post

Certain genes make type 2 diabetics more prone to hardening of the arteries.

Who Needs Biotech VCs, Anyway?

July 15, 2014 – 10:02 am | Edit Post
Who Needs Biotech VCs, Anyway?

Welcome to In Translation, and thanks for reading. As a companion to Xconomy’s regular life sciences coverage, this new column provides me with a chance to dive a little more deeply into…

[[Click headline to continue reading.]]

Who Needs Biotech VCs, Anyway?

July 15, 2014 – 10:02 am | Edit Post
Who Needs Biotech VCs, Anyway?

Welcome to In Translation, and thanks for reading. As a companion to Xconomy’s regular life sciences coverage, this new column provides me with a chance to dive a little more deeply into…

[[Click headline to continue reading.]]

UC San Diego Health System Retains No. 1 Ranking

July 15, 2014 – 9:15 am | Edit Post
UC San Diego Health System Retains No. 1 Ranking

UC San Diego Health System remains among the nation’s best, according to the U.S. News & World Report’s 2014-15 issue of “America’s Best Hospitals,” released this week. The magazine’s widely cited findings again placed UC San Diego Health System first in the San Diego metropolitan area and fifth in California, with national rankings in 11 specialties, up from 10 last year. This is comparable to the country’s most prestigious health care institutions.

Illumina expanding, with San Diego’s help

July 15, 2014 – 1:00 am | Edit Post

Genome sequencing giant Illumina, San Diego’s biggest biotech, is getting bigger.

Hera Therapeutics Raises $1.1M in Equity Financing

July 14, 2014 – 4:03 pm | Edit Post

Hera Therapeutics Inc., a biotech startup operating in the Janssen Labs incubator, has raised $1.1 million in equity financing from 14 investors, according to a July 9 filing with the U.S. Securities and Exchange Commission.